211 related articles for article (PubMed ID: 9112644)
1. Studies on the interaction of antidepressant drugs with adrenocorticotropic hormone or prednisone in rats.
Pietrasiewicz T; Zebrowska-Lupina I
Pol J Pharmacol; 1996; 48(2):145-52. PubMed ID: 9112644
[TBL] [Abstract][Full Text] [Related]
2. ACTH 4-9 analogue facilitates the antiimmobility effect of antidepressants and dopamine agonists in swimming rats.
Zebrowska-Lupina I; Pietrasiewicz T; Ossowska G; Lupina T; Klenk-Majewska B
J Physiol Pharmacol; 1997 Jun; 48(2):263-75. PubMed ID: 9223030
[TBL] [Abstract][Full Text] [Related]
3. Effects of combined treatment with imipramine and metyrapone in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
Rogóz Z; Skuza G; Wójcikowski J; Daniel WA
Pol J Pharmacol; 2003; 55(6):993-9. PubMed ID: 14730094
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
Rogóz Z; Skuza G; Kuśmider M; Wójcikowski J; Kot M; Daniel WA
Pol J Pharmacol; 2004; 56(2):179-85. PubMed ID: 15156068
[TBL] [Abstract][Full Text] [Related]
5. Influence of antiepileptics on efficacy of antidepressant drugs in forced swimming test.
Szymczyk G; Zebrowska-Lupina I
Pol J Pharmacol; 2000; 52(5):337-44. PubMed ID: 11334225
[TBL] [Abstract][Full Text] [Related]
6. Comparison of behavioural effects of venlafaxine and imipramine in rats.
Nowakowska E; Kus K; Chodera A
Arzneimittelforschung; 2003; 53(4):237-42. PubMed ID: 12785118
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice.
Poleszak E; Wlaź P; Szewczyk B; Kedzierska E; Wyska E; Librowski T; Szymura-Oleksiak J; Fidecka S; Pilc A; Nowak G
Pharmacol Biochem Behav; 2005 Jul; 81(3):524-9. PubMed ID: 15936065
[TBL] [Abstract][Full Text] [Related]
8. Effect of Withania somnifera on forced swimming test induced immobility in mice and its interaction with various drugs.
Shah PC; Trivedi NA; Bhatt JD; Hemavathi KG
Indian J Physiol Pharmacol; 2006; 50(4):409-15. PubMed ID: 17402272
[TBL] [Abstract][Full Text] [Related]
9. The effect of antidepressants on behavioral despair in rats.
Górka Z; Wojtasik E
Pol J Pharmacol Pharm; 1980; 32(4):463-8. PubMed ID: 7196038
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like effect of hyperbaric oxygen treatment in forced-swimming test in rats.
Sumen-Secgin G; Cimsit M; Ozek M; Eroglu L
Methods Find Exp Clin Pharmacol; 2005 Sep; 27(7):471-4. PubMed ID: 16258591
[TBL] [Abstract][Full Text] [Related]
11. Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels.
Walker AJ; Burnett SA; Hasebe K; McGillivray JA; Gray LJ; McGee SL; Walder K; Berk M; Tye SJ
Behav Brain Res; 2013 Apr; 242():76-83. PubMed ID: 23276607
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of amantadine and imipramine in the forced swimming test.
Maj J; Rogóz Z
Pol J Pharmacol; 2000; 52(2):111-4. PubMed ID: 10949113
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
Brocco M; Dekeyne A; Papp M; Millan MJ
Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
[TBL] [Abstract][Full Text] [Related]
14. Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA.
Kitamura Y; Fujitani Y; Kitagawa K; Miyazaki T; Sagara H; Kawasaki H; Shibata K; Sendo T; Gomita Y
Biol Pharm Bull; 2008 Feb; 31(2):246-9. PubMed ID: 18239281
[TBL] [Abstract][Full Text] [Related]
15. Suppression of histamine-induced adrenocorticotropic hormone release by antihistamines and antidepressants.
Reilly MA; Sigg EB
J Pharmacol Exp Ther; 1982 Sep; 222(3):583-8. PubMed ID: 6125582
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of antidepressants against chronic fatigue syndrome-induced behavioral changes and biochemical alterations.
Kumar A; Garg R
Fundam Clin Pharmacol; 2009 Feb; 23(1):89-95. PubMed ID: 19207541
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant effect of Yueju-Wan ethanol extract and its fractions in mice models of despair.
Wei XH; Cheng XM; Shen JS; Wang ZT
J Ethnopharmacol; 2008 May; 117(2):339-44. PubMed ID: 18343064
[TBL] [Abstract][Full Text] [Related]
18. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.
Pałucha A; Brański P; Szewczyk B; Wierońska JM; Kłak K; Pilc A
Pharmacol Biochem Behav; 2005 Aug; 81(4):901-6. PubMed ID: 16040106
[TBL] [Abstract][Full Text] [Related]
19. Effect of ACTH on the imipramine- and desipramine-induced decrease in duration of immobility time as measured in a rat forced swimming test.
Takamori K; Yoshida S; Okuyama S
Life Sci; 2001 Sep; 69(16):1891-6. PubMed ID: 11693269
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of caffeine on the antidepressant-like effect of amitriptyline in female rat subpopulations with low and high immobility in the forced swimming test.
Enríquez-Castillo A; Alamilla J; Barral J; Gourbière S; Flores-Serrano AG; Góngora-Alfaro JL; Pineda JC
Physiol Behav; 2008 Jun; 94(3):501-9. PubMed ID: 18436269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
